Effect of citicoline on lesion volume in acute stroke "Citicoline 010"

Completed

Phase 2 Results

Summary of Purpose

To investigate the effect of a daily dose of 500 mg citicoline on the evolution of ischemic lesions in acute stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 March 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Interneuron Pharmaceuticals, Lexington, MA

Trial Design

Multicenter, double blind, placebo controlled trial of 100 patients at 17 U.S. centers.

Contacts

Not available